Motivational Interviewing for Chronic Kidney Failure Adherence

Recruiting in Palo Alto (17 mi)

+5 other locations

Overseen by Ebele M Umeukeje, MD, MPH

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Vanderbilt University Medical Center

Disqualifiers: Non-African American, Severe illness, Non-English, others

No Placebo Group

Trial Summary

What is the purpose of this trial?

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on motivational interviewing to improve adherence to hemodialysis treatment.

What data supports the effectiveness of the treatment Motivational Interviewing for Chronic Kidney Failure Adherence?

Research shows that motivational interviewing can improve adherence to medical treatments and enhance emotional well-being in patients with chronic kidney disease. Studies have found that patients receiving motivational interviewing reported better adherence, lower depression and anxiety, and improved quality of life. ^{1 2 3 4 5}

Is motivational interviewing safe for humans?

Motivational interviewing has been used safely in various studies to help people manage chronic conditions like high blood pressure and kidney disease. There are no reports of harmful effects from using this approach in these studies. ^{1 3 4 5 6}

How is motivational interviewing different from other treatments for chronic kidney failure?

Motivational interviewing is unique because it focuses on enhancing a patient's own motivation to change, rather than relying on persuasion from healthcare providers. This patient-centered approach helps individuals with chronic kidney disease better adhere to their treatment plans by addressing their personal ambivalence and encouraging self-motivation. ^{1 3 4 5 7}

Eligibility Criteria

The MoVE Trial is for African American adults who are on hemodialysis for kidney failure and have missed or shortened at least one dialysis session. It's not for those planning a transplant, switching to peritoneal dialysis soon, with severe illness or mental impairment, non-English speakers, without documented non-adherence issues, hospitalized or excused absences from treatment.

Inclusion Criteria

I am 18 years old or older.

I am currently undergoing hemodialysis.

I have missed or shortened a dialysis session in the last 2 months.

Exclusion Criteria

I am scheduled for a transplant within the next 6 months.

I am planning to switch to peritoneal dialysis soon.

You have not missed any dialysis treatments without a good reason.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive motivational interviewing intervention and complete surveys

24 weeks

Regular sessions with health coaches

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Motivational interviewing (Behavioral Intervention)

Trial Overview This trial tests if motivational interviewing by health coaches can help patients stick to their hemodialysis schedule. Participants will be randomly placed into two groups: one receiving the intervention and the other not. They'll complete surveys and attend sessions over 24 weeks.

Participant Groups

Group I: Participants receiving intervention Experimental Treatment 1 Intervention

Motivational interviewing intervention

Group II: Standard of Care Active Control 1 Intervention

Standard of Care

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Buttonwood DaVita Dialysis 449 N Broad St, Philadelphia, PA 19123, PA

DaVita Philadelphia PMC Dialysis Philadelphia, PA

DaVita University City Dialysis Philadelphia, PA

Dialysis Clinic, Inc. Nashville, TN

More Trial Locations

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center Lead Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Collaborator

References

1. Switzerland pubmed.ncbi.nlm.nih.gov

Motivational interviewing to engage patients in chronic kidney disease management. [2021] Patients with chronic kidney disease (CKD) must manage numerous medical treatments and lifestyle changes that strain their treatment adherence. An important strategy to improve adherence is to activate the patients' motivation to manage their CKD. This article describes an approach for enhancing patients' motivation for change, called motivational interviewing (MI), a treatment that is increasingly being used in health care settings to counsel patients with chronic diseases. Its basic principles, techniques, empirical support, published applications for improving CKD patients' self-management, and how to learn MI are presented. Research is needed to determine the efficacy and mechanisms of MI for CKD treatment as well as the development of innovative ways to deliver it to patients and train busy health care practitioners in the approach.

2. United States pubmed.ncbi.nlm.nih.gov

Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease. [2022] Low rates of adherence to medical treatments and adverse emotional states are a widespread problem in advanced chronic kidney disease (ACKD). Motivational interviewing using the stages of change model is an effective combination in promoting behavior modifications. The objective of the present study was to determine the effectiveness of an individual, pre-dialysis intervention program (monthly sessions of 90 min over a 6-month period) in terms of adherence, emotional state and health-related quality of life (HRQL). Forty-two patients were evaluated for adherence, depression, anxiety and HRQL with standardized self-report questionnaires. Biochemical markers were also registered. The results show that after the intervention, patients reported significantly higher levels of adherence, lower depression and anxiety levels, and better HRQL (i.e., general health and emotional role domains). Biochemical parameters were controlled significantly better after the intervention, except for iPTH. These findings highlight the potential benefit of applying individual psycho-educational intervention programs based on motivational interviewing and using the stages of change model to promote adherence and wellbeing in ACKD patients.

3. United States pubmed.ncbi.nlm.nih.gov

An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. [2022] Hypertension disproportionately affects African Americans compared to whites, and it is the single most common explanation for the disparity in mortality between African Americans and whites. Adherence with antihypertensive medications can help reduce risk of negative hypertension-related outcomes. Motivational interviewing is a promising patient-centered approach for improving adherence in patients with chronic diseases. In this paper we describe the rationale and design of an ongoing randomized controlled trial testing the effectiveness of motivational interviewing versus usual care in improving medication adherence among 190 African American uncontrolled hypertensive patients, who receive care in a primary care setting.

4. United States pubmed.ncbi.nlm.nih.gov

The Effect of Motivational Interviewing on Adherence to Treatment and Quality of Life in Chronic Hemodialysis Patients: A Randomized Controlled Trial. [2021] The aim of this study was to determine the effect of motivational interviewing (MI) on adherence to treatment and quality of life in chronic hemodialysis patients. This study was conducted with a randomized controlled pretest, posttest, and follow-up design from March to July 2016 in the hemodialysis center. After the intervention (n = 30) and control groups (n = 30) completed a pretest, patients in the intervention group received four individual face-to face MI sessions per month. Then both groups participated in a posttest, 3 months after which a follow-up was conducted. A significant increase in adherence to treatment (according to both subjective and objective data) was observed in the experimental group compared to the control group. No significant difference was found between the two groups in their quality of life scores; however, within the experimental group, there was a significant increase in these scores between the posttest and the 3-month follow-up.

5. United States pubmed.ncbi.nlm.nih.gov

Motivational Interviewing in Dialysis Adherence Study (MIDAS). [2022] To examine the feasibility and efficacy of a staff-delivered motivational interviewing technique on treatment, diet, medication, and fluid adherence in adult patients receiving outpatient hemodialysis.

6. England pubmed.ncbi.nlm.nih.gov

Motivational interviewing to explore culturally and linguistically diverse people's comorbidity medication self-efficacy. [2018] To examine the perceptions of a group of culturally and linguistically diverse participants with the comorbidities of diabetes, chronic kidney disease and cardiovascular disease to determine factors that influence their medication self-efficacy through the use of motivational interviewing.

7. Poland pubmed.ncbi.nlm.nih.gov

[The use of motivational interviewing (MI) in patients with chronic renal failure]. [2015] Patients suffering from chronic kidney disease must submit to numerous medical procedures and burdensome changes in lifestyle that make it difficult to adapt to the disease. Therefore, an important issue is to stimulate the patients motivation to comply with medical recommendations. This article describes a therapy tool for developing patient's motivation to change, called therapy or motivational interview (MI), the type of approach that is increasingly being used inhealth care, as an aid to chronically ill patients. Characteristics of this approach generally relies on the assumption that the Motivation for a change should come from a patient, not the provider, and a patient should articulate arnd resolve ambivalence provider persuassion is not effective and enhance resistance from a change. Persuasion by a person healing can only strengthen and enhance the patient's resistance to unwanted habits.